JP2021530526A5 - - Google Patents
Info
- Publication number
- JP2021530526A5 JP2021530526A5 JP2021502626A JP2021502626A JP2021530526A5 JP 2021530526 A5 JP2021530526 A5 JP 2021530526A5 JP 2021502626 A JP2021502626 A JP 2021502626A JP 2021502626 A JP2021502626 A JP 2021502626A JP 2021530526 A5 JP2021530526 A5 JP 2021530526A5
- Authority
- JP
- Japan
- Prior art keywords
- xinafoate
- carboxy
- amino
- methylpiperazine
- methoxyethyl
- Prior art date
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023171327A JP7644190B2 (ja) | 2018-07-18 | 2023-10-02 | Ｊａｋ阻害化合物のキシナホ酸塩 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862699955P | 2018-07-18 | 2018-07-18 | |
| US62/699,955 | 2018-07-18 | ||
| US201962866013P | 2019-06-25 | 2019-06-25 | |
| US62/866,013 | 2019-06-25 | ||
| PCT/EP2019/069252 WO2020016302A1 (en) | 2018-07-18 | 2019-07-17 | A xinafoate salt of a jak inhibiting compound |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023171327A Division JP7644190B2 (ja) | 2018-07-18 | 2023-10-02 | Ｊａｋ阻害化合物のキシナホ酸塩 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2021530526A JP2021530526A (ja) | 2021-11-11 |
| JPWO2020016302A5 JPWO2020016302A5 (https=) | 2022-07-19 |
| JP2021530526A5 true JP2021530526A5 (https=) | 2022-07-19 |
| JP7422732B2 JP7422732B2 (ja) | 2024-01-26 |
Family
ID=67396927
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021502626A Active JP7422732B2 (ja) | 2018-07-18 | 2019-07-17 | Ｊａｋ阻害化合物のキシナホ酸塩 |
| JP2023171327A Active JP7644190B2 (ja) | 2018-07-18 | 2023-10-02 | Ｊａｋ阻害化合物のキシナホ酸塩 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023171327A Active JP7644190B2 (ja) | 2018-07-18 | 2023-10-02 | Ｊａｋ阻害化合物のキシナホ酸塩 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US11149029B2 (https=) |
| EP (1) | EP3823964A1 (https=) |
| JP (2) | JP7422732B2 (https=) |
| KR (1) | KR102849420B1 (https=) |
| CN (2) | CN118580223A (https=) |
| AU (1) | AU2019304014B2 (https=) |
| BR (1) | BR112021000467A2 (https=) |
| CA (1) | CA3105585A1 (https=) |
| IL (1) | IL280025B2 (https=) |
| MA (1) | MA53162A (https=) |
| MX (1) | MX2021000611A (https=) |
| MY (1) | MY209356A (https=) |
| SG (1) | SG11202100240RA (https=) |
| WO (1) | WO2020016302A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115260128B (zh) * | 2022-09-21 | 2022-12-09 | 苏州凯瑞医药科技有限公司 | 一种新型jak抑制剂关键中间体的制备方法 |
| GB202316063D0 (en) | 2023-10-20 | 2023-12-06 | Astrazeneca Ab | Dosing regime |
| GB202403369D0 (en) | 2024-03-08 | 2024-04-24 | Astrazeneca Ab | Process and intermediates for the production of a jak1 inhibitor |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009031011A2 (en) | 2007-09-05 | 2009-03-12 | Pfizer Limited | Xinafoate salt of n4-(2, 2-difluoro-4h-benz0 [1,4] 0xazin-3-one) -6-yl] -5-fluoro-n2- [3- (methylaminocar bonylmethyleneoxy) phenyl] 2, 4-pyrimidinediamine |
| MX2013003019A (es) * | 2010-09-15 | 2013-05-28 | Hoffmann La Roche | Compuestos de azabenzotiazol, composiciones y metodos de uso. |
| AU2014342338B2 (en) * | 2013-11-01 | 2016-12-01 | Novartis Ag | Aminoheteroaryl benzamides as kinase inhibitors |
| PL3189045T3 (pl) | 2014-08-11 | 2022-04-04 | Sun Pharmaceutical Industries Limited | Nowe sole nilotynibu i jego polimorfy |
| BR112018005833B1 (pt) * | 2015-09-25 | 2023-10-10 | Dizal (Jiangsu) Pharmaceutical Co., Limited | Composto, sal farmaceuticamente aceitável, composição farmacêutica e uso do composto |
| KR102585048B1 (ko) | 2017-01-17 | 2023-10-05 | 아스트라제네카 아베 | Jak1 선택적 억제제 |
| CN106831538B (zh) * | 2017-01-22 | 2019-06-25 | 苏州楚凯药业有限公司 | 托法替尼中间体的制备方法 |
-
2019
- 2019-07-17 SG SG11202100240RA patent/SG11202100240RA/en unknown
- 2019-07-17 EP EP19742558.0A patent/EP3823964A1/en active Pending
- 2019-07-17 AU AU2019304014A patent/AU2019304014B2/en active Active
- 2019-07-17 CN CN202410624343.9A patent/CN118580223A/zh active Pending
- 2019-07-17 MA MA053162A patent/MA53162A/fr unknown
- 2019-07-17 MY MYPI2021000231A patent/MY209356A/en unknown
- 2019-07-17 US US16/513,781 patent/US11149029B2/en active Active
- 2019-07-17 JP JP2021502626A patent/JP7422732B2/ja active Active
- 2019-07-17 CN CN201980047093.4A patent/CN112424187B/zh active Active
- 2019-07-17 KR KR1020217001860A patent/KR102849420B1/ko active Active
- 2019-07-17 MX MX2021000611A patent/MX2021000611A/es unknown
- 2019-07-17 WO PCT/EP2019/069252 patent/WO2020016302A1/en not_active Ceased
- 2019-07-17 BR BR112021000467-0A patent/BR112021000467A2/pt unknown
- 2019-07-17 CA CA3105585A patent/CA3105585A1/en active Pending
- 2019-07-17 IL IL280025A patent/IL280025B2/en unknown
-
2023
- 2023-10-02 JP JP2023171327A patent/JP7644190B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022023891A (ja) | オメカムチブメカルビルの塩及び塩を調製するプロセス | |
| TWI726030B (zh) | 一種ｂｔｋ激酶抑制劑的結晶形式及其製備方法 | |
| JP7153030B2 (ja) | オピオイド受容体（ｍｏｒ）アゴニスト塩、そのフマレート塩ｉ結晶形態、およびその製造方法 | |
| JP6170146B2 (ja) | チロシンキナーゼ阻害剤二マレイン酸塩のｉ型結晶およびその製造法 | |
| JP2021530526A5 (https=) | ||
| TWI799431B (zh) | RORγ抑制劑 | |
| JP2013525384A (ja) | ニトロイミダゾール系化合物、その製造方法および用途 | |
| CN114075169B (zh) | 奥希替尼药用共晶体及其制备方法 | |
| JP2024530315A (ja) | Ｂｃｌ－２阻害剤の固体形態、それらの調製方法及び使用方法 | |
| JPWO2020016302A5 (https=) | ||
| TW201904954A (zh) | 一種苯并哌啶類衍生物的鹽、其晶型及鹽、其晶型的製備方法 | |
| TWI745764B (zh) | 一種鴉片類物質受體激動劑的結晶形式及製備方法 | |
| HUE030298T2 (en) | (1,1-Dioxo-4-thiomorpholinyl) - [6 - [[3- (4-fluorophenyl) -5-methyl-4-isoxazolyl] methoxy] -3-pyridinyl] methanone | |
| CN111662216A (zh) | 一种金刚烷胺类化合物的晶型及其制备方法 | |
| TWI708764B (zh) | 一種雄性激素受體抑制劑的結晶形式及其製備方法 | |
| TWI717859B (zh) | 一種鴉片類物質受體激動劑的結晶形式及製備方法 | |
| JP7394773B2 (ja) | ビス－コリンテトラチオモリブデートの製造方法 | |
| CN115803329A (zh) | 八氢噻吩并喹啉化合物的琥珀酸盐及其晶体 | |
| WO2011115173A1 (ja) | ベンゾチアジン化合物のモノマレイン酸塩 | |
| WO2013082302A1 (en) | Agomelatine-urea complex and crystalline forms thereof | |
| JP2013049632A (ja) | ベンゾチアジン化合物のモノマレイン酸塩を有効成分とするアレルギー疾患の予防及び／又は治療剤 | |
| HK40090484A (zh) | 八氢噻吩并喹啉化合物的琥珀酸盐及其晶体 | |
| US20110184067A1 (en) | O-desmethylvenlafaxine succinate polymorph & process for preparing thereof | |
| WO2025019598A1 (en) | Positive allosteric modulator of the metabotropic glutamate receptor subtype 2 receptor, synthesis and solid forms thereof | |
| TW202540105A (zh) | 1-((3S,4R)-3-((2-((1-乙基-1H-吡唑-4-基)胺基)-7H-吡咯并[2,3-d]嘧啶-4-基)氧基)-4-氟哌啶-1-基)丙-2-烯-1-酮之酒石酸鹽、其結晶形式及其製備方法 |